Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Receivables (2022 - 2025)

Envoy Medical's Receivables history spans 4 years, with the latest figure at $53000.0 for Q4 2025.

  • Quarterly results put Receivables at $53000.0 for Q4 2025, down 93.52% from a year ago — trailing twelve months through Dec 2025 was $53000.0 (down 93.52% YoY), and the annual figure for FY2025 was $53000.0, down 93.52%.
  • Receivables for Q4 2025 was $53000.0 at Envoy Medical, down from $54000.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.1 million in Q3 2023 to a low of $41000.0 in Q4 2022.
  • The 4-year median for Receivables is $202000.0 (2024), against an average of $281909.1.
  • The sharpest move saw Receivables skyrocketed 500.0% in 2023, then plummeted 93.52% in 2025.
  • Year by year, Receivables stood at $41000.0 in 2022, then skyrocketed by 500.0% to $246000.0 in 2023, then surged by 232.52% to $818000.0 in 2024, then plummeted by 93.52% to $53000.0 in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $53000.0, $54000.0, and $63000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.